0001062993-23-018421.txt : 20230922
0001062993-23-018421.hdr.sgml : 20230922
20230922183939
ACCESSION NUMBER: 0001062993-23-018421
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230920
FILED AS OF DATE: 20230922
DATE AS OF CHANGE: 20230922
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lapidus Stanley
CENTRAL INDEX KEY: 0001678195
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40901
FILM NUMBER: 231272730
MAIL ADDRESS:
STREET 1: 101 HARTWELL AVE.
CITY: LEXINGTON
STATE: MA
ZIP: 02421
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lucid Diagnostics Inc.
CENTRAL INDEX KEY: 0001799011
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 825488042
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 360 MADISON AVENUE
STREET 2: 25TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212 949 4319
MAIL ADDRESS:
STREET 1: 360 MADISON AVENUE
STREET 2: 25TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10017
4
1
form4.xml
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
X0508
4
2023-09-20
0001799011
Lucid Diagnostics Inc.
LUCD
0001678195
Lapidus Stanley
360 MADISON AVENUE, 25TH FLOOR
NEW YORK
NY
10017
1
0
0
0
0
Common stock
2023-09-20
4
S
0
3405
1.45
D
132051
D
Common stock
2023-09-20
4
S
0
412
1.44
D
131639
D
Common stock
2023-09-21
4
S
0
100
1.44
D
131539
D
Each sale was in connection with the Reporting Person's estimated income tax withholdings related to vested restricted stock.
Represents shares the Reporting Person received as a restricted stock grant under the Issuer's 2018 Equity Plan. Such grant was 169,320 shares of common stock, 50% of which vested September 20, 2022 and 50% of which vested September 20, 2023.
/s/ Michael A. Gordon, by power of attorney
2023-09-22